Welcome to our new Folding forum for discussion about our new Folding team! I heard of FAH years ago but for whatever reason never got into it, preferring to crunch BOINC projects instead, but I always thought it was a worthwhile project. Today, it's still going strong and may be even better known than BOINC. Last month when GPUGrid was short on work I decided to give it a try. I found the software fairly easy to set up, the only difficulty I had was getting it to run on the correct GPU, not unexpected when you have a multiple GPU system. I also looked for our USA team, and I did find a USA team but there was no evident link to our BOINC team.
Yesterday I took the plunge and created a new Folding (hereafter FAH) team that's directly linked to our site here, and our BOINC efforts. There were multiple reasons for that:
Now for the particulars. If you're interested in exactly what this project is researching, look here. Understand that unlike BOINC, where a project is basically run by a single team, multiple entities are submitting work to FAH. You can pick what you'd prefer to crunch, but if no work for that project is available you will get work from another. I don't mind this as I do have my preference but it's all worthwhile. Currently you can choose to prioritize Cancer, Alzheimer's, Parkinsons or Huntington's disease. There is also the Any category which means all work is treated equally. There's an FAQ here if you'd like to learn more.
Yesterday I took the plunge and created a new Folding (hereafter FAH) team that's directly linked to our site here, and our BOINC efforts. There were multiple reasons for that:
- There's no mechanism to contact whoever started the other team and coordinate efforts with our BOINC team.
- The FAH team page URL has some political connotations and I'd prefer to keep the focus on crunching and science.
- I only recognized one! BOINC team member's name.
- The time seemed right as people are interested in the coronavirus and FAH will be starting a project dedicated to that research shortly.
- SETI's hibernation means there will be a lot of potential crunching power available, if our team mates are interested.
Now for the particulars. If you're interested in exactly what this project is researching, look here. Understand that unlike BOINC, where a project is basically run by a single team, multiple entities are submitting work to FAH. You can pick what you'd prefer to crunch, but if no work for that project is available you will get work from another. I don't mind this as I do have my preference but it's all worthwhile. Currently you can choose to prioritize Cancer, Alzheimer's, Parkinsons or Huntington's disease. There is also the Any category which means all work is treated equally. There's an FAQ here if you'd like to learn more.
- To get started, download the FAH software. I've only run the Windows client so far, I will try Linux eventually (hopefully soon!).
- Everything is controlled from your client, there are no web preferences like BOINC has. The software comes with the FAHControl manager, similar to the BOINC manager, and a web controller which uses your browser. The web browser is simpler to use, but doesn't offer the level of control the advanced option does. FAH assumes you want to use your whole computer to fold; if you don't you'll need to use the advanced controller to set things to your liking.
- The web controller connects to http://client.foldingathome.org/ and establishes a local connection. Chromium-based browsers seem to work fine but I had manually enter 127.0.0.1:7396 in my Firefox-based browser.
- Make sure to get your Passkey. It's similar to the CPID used by BOINC, but it also directly affects stats, without it you won't qualify for the QRB (Quick Return Bonus).
- Since there's no project website to join teams etc. you join via one of the controllers. That's also where you enter your name. I encourage you to use your BOINC alias if you have one. Here's how to do it via FAHControl. The team is named BOINC.USA and the number is 236370. You'll only need to enter the number.